Weather New York, NY +77°F

Regions

NVM Private Equity funds Cleveland Biotech

June 17
8:55 AM 2013
Biotechnology
(Photo : Reuters)
The image is a biotechnology lab that is the subject of investments by Tullis Health Investors.

NVM Private Equity, a British firm, recently gave its support on the management buyout of Cleveland Biotech, a company which provides eco-friendly biological waste management and treatment products. The backing, worth £3 million, is in support if the  £4.4 million buyout .

Management operation and leadership of Cleveland Biotech will change, prompting an organic business model. This also takes advantage of the expected growth potential in prevailing and new markets across the Euro zone.

Cleveland Biotech's flagship product is Nitrifying Bacteria. The said bioproduct is distributed to water treatment facilities. It degrades organic pollutants naturally, including grease, oil, fat, uric acid, limescale, and diesel. The company focuses, however, on FOG (fat, oil, and grease) management.

CBio said that it has reached double the amount of its exports in Europe due to Lithuanian sales orders. The orders were for British patented pro-biotic sanitary products.

Analysts agree that organic and environmentally friendly cleaning agents will wipe out the traditional cleaning product market especially in the Baltic region.

© 2017 VCPOST, All rights reserved. Do not reproduce without permission.
Tags
Share

Comments

Join the Conversation

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics